Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 4 Prostatic Neoplasms 3 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatitis, Chronic 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neurocognitive Disorders 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immunoglobulin G4-Related Disease 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Autoimmune Pancreatitis 1 Anus Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anal Canal Carcinoma 1

Interventions

pembrolizumab 14 Paclitaxel 14 Carboplatin 12 Bevacizumab 7 Specimen Handling 6 Cisplatin 6 olaparib 5 Taxes 5 Fulvestrant 5 Nivolumab 4 Megestrol Acetate 4 Magnetic Resonance Spectroscopy 4 Doxorubicin 4 Biopsy 4 palbociclib 3 durvalumab 3 Oxaliplatin 3 Leucovorin 3 Letrozole 3 Immunoglobulin G 3 Gemcitabine 3 Fluorouracil 3 Docetaxel 3 Disulfides 3 trastuzumab deruxtecan 2 ribociclib 2 pertuzumab 2 lenvatinib 2 ipatasertib 2 dostarlimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × Observation × 30 days × Clear all

NCT05255653 2026-05-15

RAINBO

Leiden University Medical Center

Phase 2/3 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡